OTCMKTS:PVOTF - Pivot Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.1791 0.00 (0.00 %)
(As of 01/17/2019 09:55 AM ET)
Previous Close$0.1792
Today's Range$0.1791 - $0.1791
52-Week Range$0.0801 - $2.27
Volume500 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Pivot Pharmaceuticals Inc., a development stage pharmaceutical and nutraceutical company, engages in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using drug delivery platform technologies in Canada. The company offers its products for cancer supportive care, pain and inflammation, women's sexual dysfunction, dermatology, and eye diseases. It also focuses on the research, development, and commercialization of cannabinoid based nutraceuticals. The company was formerly known as Neurokine Pharmaceuticals Inc. and changed its name to Pivot Pharmaceuticals Inc. in April 2015. Pivot Pharmaceuticals Inc. was founded in 2002 and is based in Vancouver, Canada.

Receive PVOTF News and Ratings via Email

Sign-up to receive the latest news and ratings for PVOTF and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations


Current Ratio0.15
Quick Ratio0.15


Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Price / Cash FlowN/A
Price / BookN/A


Net Income$-120,000.00
Net MarginsN/A
Return on Assets-85.25%


OptionableNot Optionable

Pivot Pharmaceuticals (OTCMKTS:PVOTF) Frequently Asked Questions

What is Pivot Pharmaceuticals' stock symbol?

Pivot Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PVOTF."

How were Pivot Pharmaceuticals' earnings last quarter?

Pivot Pharmaceuticals Inc (OTCMKTS:PVOTF) issued its quarterly earnings results on Tuesday, December, 18th. The company reported ($0.02) EPS for the quarter. View Pivot Pharmaceuticals' Earnings History.

When is Pivot Pharmaceuticals' next earnings date?

Pivot Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Tuesday, May 7th 2019. View Earnings Estimates for Pivot Pharmaceuticals.

Has Pivot Pharmaceuticals been receiving favorable news coverage?

News articles about PVOTF stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Pivot Pharmaceuticals earned a news sentiment score of -1.6 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future.

Who are some of Pivot Pharmaceuticals' key competitors?

Who are Pivot Pharmaceuticals' key executives?

Pivot Pharmaceuticals' management team includes the folowing people:
  • Dr. Patrick Charles Frankham, CEO, Pres & Director (Age 48)
  • Ms. Moira Ong, Chief Financial Officer (Age 44)
  • Dr. Ahmad Doroudian, Advisor (Age 59)
  • Dr. Joseph Borovsky, Chairman, Exec. VP of Product Devel. & Member of Scientific Advisory Board
  • Dr. Wolfgang Renz M.D., Ph.D., Chief Medical Officer & Director (Age 50)

How do I buy shares of Pivot Pharmaceuticals?

Shares of PVOTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Pivot Pharmaceuticals' stock price today?

One share of PVOTF stock can currently be purchased for approximately $0.1792.

What is Pivot Pharmaceuticals' official website?

The official website for Pivot Pharmaceuticals is http://www.pivotpharma.com.

How can I contact Pivot Pharmaceuticals?

Pivot Pharmaceuticals' mailing address is 1275 WEST 6TH AVENUE, VANCOUVER A1, V6H 1A6. The company can be reached via phone at 604-805-7783.

MarketBeat Community Rating for Pivot Pharmaceuticals (OTCMKTS PVOTF)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  42 (Vote Outperform)
Underperform Votes:  37 (Vote Underperform)
Total Votes:  79
MarketBeat's community ratings are surveys of what our community members think about Pivot Pharmaceuticals and other stocks. Vote "Outperform" if you believe PVOTF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PVOTF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel